BioLife Sciences Inc.
BLFE · OTC
11/30/2020 | 11/30/2019 | 11/30/2018 | 11/30/2017 | |
|---|---|---|---|---|
| Market Cap | $58,509 | $45,708 | $45,708 | $10,458 |
| - Cash | $35 | $0 | $1 | $12 |
| + Debt | $190 | $0 | $142 | $141 |
| Enterprise Value | $58,664 | $45,708 | $45,849 | $10,586 |
| Revenue | $412 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$985 | $0 | $0 | $0 |
| % Margin | -239.3% | – | – | – |
| EBITDA | -$1,218 | $172 | -$42 | -$329 |
| % Margin | -295.9% | – | – | – |
| Net Income | -$1,268 | -$1 | -$53 | -$340 |
| % Margin | -308% | – | – | – |
| EPS Diluted | -0.025 | -0 | -0.003 | -0.077 |
| % Growth | -24,400% | 96.3% | 96.5% | – |
| Operating Cash Flow | -$884 | $0 | -$13 | -$19 |
| Capital Expenditures | -$1 | $0 | $0 | $0 |
| Free Cash Flow | -$885 | $0 | -$13 | -$19 |